Xi Jinping embarked on a charm offensive ahead of Trump’s reciprocal tariffs, but political pressure on a Hong Kong company could derail those efforts.
From Jan. 1, 2026, a health insurer will not be able to fund organ transplant surgery if the operation takes place in China or the organ is from China.
‘This bill pushes back on Beijing’s inclination to bully smaller countries and limit Taiwan’s global network of partners,’ Rep. Raja Krishnamoorthi said.
Experts say the road to reciprocity will be bumpy but necessary. One, in particular, expects to see early signs of an economic boom before the 2026 midterms.
Article 7 of the regulations allows the regime to openly seize foreign businesses’ intellectual property, said former Chinese rights lawyer Wu Shaoping.
China has struggled to reverse the decline in foreign investment, especially as its economy braces for the impact of additional tariffs imposed by Washington.
The CCP in recent years has stepped up its sabotage campaign against the performing arts company, representatives said at a Lincoln Center press conference.